Fastest Growing Cannabis Stocks
Updated March 2026Cannabis companies with the highest year-over-year revenue growth rates, ranked from fastest to slowest growers.
Revenue growth is one of the most important metrics for evaluating cannabis stocks because the industry is still in its early expansion phase. Companies that are growing revenue quickly are capturing market share in new and existing state markets, scaling operations efficiently, and positioning themselves to benefit from eventual federal legalization. In a sector where most companies are not yet profitable, revenue growth serves as the primary signal of business momentum.
The fastest-growing cannabis stocks tend to fall into a few categories: MSOs aggressively expanding into newly legal states, smaller operators that recently came online and are still ramping up, and ancillary companies riding the growth of their plant-touching customers. It is important to distinguish between organic growth (driven by same-store sales and new store openings) and acquisition-driven growth, which can look impressive on paper but may not be sustainable if funded by dilutive capital raises.
Below you will find every cannabis company with positive year-over-year revenue growth, ranked from the fastest grower to the slowest. Cross-reference these growth rates with margins and cash flow to identify companies that are growing profitably versus those burning cash to chase top-line numbers.
Fastest Growing Cannabis Stocks — Full Rankings
30 stocks · Ranked by rev growth yoy
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Rev Growth YoY |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals | $195.02 | -0.44% | $11.60B | $4.16B | — | 2.77x | +0.0% |
| 2 | SMG | Scotts Miracle-Gro | $64.51 | -0.14% | $3.74B | $3.35B | 3098.2% | 1.10x | +0.0% |
| 3 | CURLF | Curaleaf Holdings | $2.36 | +2.83% | $1.80B | $0 | — | — | +0.0% |
| 4 | GTBIF | Green Thumb Industries | $6.56 | +7.01% | $1.54B | $0 | — | — | +0.0% |
| 5 | TPB | Turning Point Brands | $73.50 | -0.09% | $1.44B | $463.1M | 5708.0% | 3.08x | +0.0% |
| 6 | IIPR | Innovative Industrial Properties | $50.20 | -0.30% | $1.39B | $276.0M | — | 5.03x | +0.0% |
| 7 | TCNNF | Trulieve Cannabis | $6.40 | +4.92% | $1.22B | $0 | — | — | +0.0% |
| 8 | CRON | Cronos Group | $2.56 | -0.20% | $939.0M | $146.6M | 4281.3% | 6.63x | +0.0% |
| 9 | MSOS | AdvisorShares Pure US Cannabis ETF | $3.83 | -0.26% | $781.3M | $0 | — | — | +0.0% |
| 10 | TLRY | Tilray Brands | $6.75 | -0.59% | $764.3M | $858.3M | 2767.8% | 0.89x | +0.0% |
| 11 | GLASF | Glass House Brands | $7.50 | -2.72% | $608.3M | $0 | — | — | +0.0% |
| 12 | VRNOF | Verano Holdings | $1.26 | -8.70% | $457.6M | $0 | — | — | +0.0% |
| 13 | CGC | Canopy Growth | $1.02 | -0.36% | $391.1M | $278.4M | 2584.6% | 1.35x | +0.0% |
| 14 | NLCP | NewLake Capital Partners | $15.43 | -1.09% | $370.3M | $0 | — | — | +0.0% |
| 15 | INNPF | InnocanPharma | $5.07 | 0.00% | $354.9M | $0 | — | — | +0.0% |
| 16 | CRLBF | Cresco Labs | $0.97 | -0.27% | $346.1M | $0 | — | — | +0.0% |
| 17 | SNDL | SNDL Inc | $1.36 | 0.00% | $344.8M | $0 | — | — | +0.0% |
| 18 | VFF | Village Farms International | $2.69 | -1.10% | $316.5M | $253.3M | 3349.1% | 1.25x | +0.0% |
| 19 | PLNHF | Planet 13 Holdings | $0.91 | +5.21% | $295.8M | $0 | — | — | +0.0% |
| 20 | TSNDF | TerrAscend Corp | $0.68 | +0.37% | $261.4M | $0 | — | — | +0.0% |
| 21 | REFI | Chicago Atlantic Real Estate Finance | $11.37 | +0.34% | $240.3M | $55.4M | — | 4.16x | +0.0% |
| 22 | HITI | High Tide Inc | $2.31 | -0.43% | $204.8M | $0 | — | — | +0.0% |
| 23 | ACB | Aurora Cannabis | $3.42 | -0.88% | $193.3M | $0 | — | — | +0.0% |
| 24 | OGI | Organigram Holdings | $1.40 | -0.25% | $190.8M | $0 | — | — | +0.0% |
| 25 | GDNSF | Vireo Growth (Goodness Growth) | $0.44 | -1.12% | $182.2M | $0 | — | — | +0.0% |
| 26 | MJ | ETFMG Alternative Harvest ETF | $24.16 | -0.31% | $119.7M | $0 | — | — | +0.0% |
| 27 | CBWTF | Auxly Cannabis Group | $0.09 | +1.07% | $111.6M | $0 | — | — | +0.0% |
| 28 | CWBHF | Charlotte's Web Holdings | $0.62 | -0.22% | $99.3M | $0 | — | — | +0.0% |
| 29 | JUSHF | Jushi Holdings | $0.49 | -0.26% | $96.4M | $0 | — | — | +0.0% |
| 30 | AGFY | Agrify Corp | $47.12 | +4.71% | $94.2M | $15.4M | 5172.8% | 6.12x | +0.0% |
Top 3 Spotlight
Jazz Pharmaceuticals
Jazz Pharmaceuticals ranks #1 in the fastest growing cannabis stocks category with a share price of $195.02 and a market capitalization of $11.60B. The company operates in the Biotech sector and is listed on the NASDAQ. With trailing twelve-month revenue of $4.16B and a gross margin of N/A, JAZZ represents the top-ranked stock in this category based on rev growth yoy.
Scotts Miracle-Gro
Scotts Miracle-Gro ranks #2 in the fastest growing cannabis stocks category with a share price of $64.51 and a market capitalization of $3.74B. The company operates in the Ancillary sector and is listed on the NYSE. With trailing twelve-month revenue of $3.35B and a gross margin of 3098.2%, SMG represents the second-ranked stock in this category based on rev growth yoy.
Curaleaf Holdings
Curaleaf Holdings ranks #3 in the fastest growing cannabis stocks category with a share price of $2.36 and a market capitalization of $1.80B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, CURLF represents the third-ranked stock in this category based on rev growth yoy.
Methodology
Stocks are filtered to include only companies with positive year-over-year revenue growth and ranked in descending order by revenue growth rate percentage. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 30 qualifying stocks out of 94 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the fastest growing cannabis stocks category is JAZZ (Jazz Pharmaceuticals) with a rev growth yoy of +0.0%. The stock trades at $195.02 per share with a market capitalization of $11.60B. In second place is SMG (+0.0%), followed by CURLF (+0.0%) in third.
Across all 30 qualifying stocks, the average share price is $18.00 and the average market capitalization is $1.02B. The combined trailing twelve-month revenue of all companies in this category is $9.86B. The average gross margin among companies with positive margins is 3851.7%. The average price-to-sales ratio is 3.24x.
The most represented sector in this category is MSO with 10 out of 30 companies (33%). Among the ranked stocks, 8 are trading higher today while 20 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the fastest growing cannabis stocks category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by rev growth yoy may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
High revenue growth does not guarantee investment returns. Many fast-growing cannabis companies achieve their growth rates through aggressive capital spending, new store openings funded by debt or equity issuance, and acquisitions that may not generate attractive returns on invested capital. Growth stocks in cannabis are particularly vulnerable to execution risk — a company expanding into three new states simultaneously may spread management too thin. Additionally, revenue growth rates naturally decelerate as companies scale, and the market may reprice a stock sharply lower when growth slows from 80% to 30%, even if the business is healthy.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
What is a good revenue growth rate for a cannabis company?
In the current cannabis market environment, year-over-year revenue growth above 20% is considered strong, and above 40% is exceptional. However, context matters — a small company doubling revenue from $5M to $10M is less impressive than a large MSO growing from $500M to $700M. Compare growth rates within peer groups of similar-sized companies and sub-sectors. Also examine sequential quarterly growth (quarter-over-quarter) to confirm the trend is not decelerating.
How do cannabis growth stocks differ from value stocks?
Growth stocks prioritize top-line expansion over current profitability, often trading at higher price-to-sales multiples because investors are paying for future earnings potential. Value stocks trade at lower multiples because growth has slowed or stalled, but they may be generating positive cash flow and returning capital to shareholders. In cannabis, the growth-vs-value spectrum maps roughly to expansion-stage MSOs (growth) versus mature Canadian LPs and ancillary companies (value). Both approaches can work depending on market conditions and your risk tolerance.
Should I only invest in cannabis companies with positive revenue growth?
Not necessarily. Some cannabis companies with negative revenue growth may be in the midst of strategic pivots — shedding unprofitable operations, exiting underperforming states, or right-sizing their cost structures. If a company is declining in revenue but dramatically improving margins and cash flow, it could be a better investment than a company growing revenue at 50% while burning through cash. The key is understanding why revenue is growing or declining and whether the trend is likely to continue.
How frequently is the growth data updated on CannaCap?
Revenue growth figures on CannaCap are updated when companies report quarterly earnings, typically within 24-48 hours of the filing. Most cannabis companies report on a quarterly basis with a 45-60 day lag after quarter-end. The year-over-year growth rate compares the most recent trailing twelve months of revenue against the prior twelve-month period, smoothing out seasonal fluctuations that can affect individual quarters.
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.